PTIX — Protagenic Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Protagenic Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.799	0.671	10.4	7.98	4.06
Prepaid Expenses
Total Current Assets	0.842	0.879	11.1	8.04	4.2
Net Property, Plant And Equipment	0	—	—	0.002	0.123
Total Assets	0.842	0.879	11.1	8.04	4.32
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.2	0.655	0.8	1.12	0.655
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	1.48	2.03	1.12	1.12	0.655
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.634	-1.15	9.94	6.92	3.67
Total Liabilities & Shareholders' Equity	0.842	0.879	11.1	8.04	4.32
Total Common Shares Outstanding
Total Preferred Shares Outstanding